EUVIMEDEUVIMED entdecken
Crossref

Impact of Chronic Sodium Cyclamate Administration at a Daily Acceptable Dose on Carbohydrate Metabolism and Insulin Resistance

Sanjarbek Khabibullaev, Nasirdjan Yuldashev, Shaira Karimova, Alimkhodjayeva Nazira, Surayyo Ikramova, Gulchekhra Suleymanova, Durdona Rashidova

International Journal of Drug Delivery Technology · 14.03.2026 · 16 (7s)

DOI: 10.25258/ijddt.16.7s.10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 14.03.2026. Verfasst von Sanjarbek Khabibullaev und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium cyclamate, a widely used non-caloric artificial sweetener, has been associated with potential metabolic disturbances. This study evaluated the effects of chronic sodium cyclamate administration (10 mg/kg/day, peroral) on carbohydrate, protein, lipid, and mineral metabolism, as well as insulin resistance and body weight, in experimental rats over 60 days. Chronic cyclamate consumption significantly increased blood glucose, glycated hemoglobin, and insulin levels, with glucose rising by 68.4% and insulin by 66.4% relative to baseline by day 60. Glucose tolerance tests revealed marked impairment, with the area under the glucose curve increasing by 73.3%. Liver glycogen content decreased by 41.83%, accompanied by elevated ALT and AST activities, indicating hepatic involvement. Biochemical analysis showed increases in total protein and albumin levels, while urea and creatinine concentrations were elevated, reflecting altered nitrogen metabolism. Lipid profile assessment revealed progressive increases in total cholesterol, triglycerides, LDL-C, HDL-C, and VLDL-C, with corresponding changes in atherogenic coefficients, suggesting negative effects on lipid metabolism. Chronic administration also disrupted mineral homeostasis, decreasing potassium and calcium levels while moderately altering sodium levels. Insulin resistance indices, including HOMA-IR, FIRI, QUICKI, and Caro index, demonstrated significant reductions in insulin sensitivity over time. Notably, body weight was slightly reduced during the experiment, indicating that sodium cyclamate did not promote weight gain under these conditions. Collectively, these findings demonstrate that prolonged sodium cyclamate intake adversely affects glucose tolerance, insulin sensitivity, and multiple metabolic parameters in rats, highlighting potential health risks associated with chronic exposure.

Zitieren

APA

Khabibullaev, S., Yuldashev, N., Karimova, S., Nazira, A., Ikramova, S., Suleymanova, G., & Rashidova, D. (2026). Impact of Chronic Sodium Cyclamate Administration at a Daily Acceptable Dose on Carbohydrate Metabolism and Insulin Resistance. International Journal of Drug Delivery Technology, 16(7s). https://doi.org/10.25258/ijddt.16.7s.10

Vancouver

Khabibullaev S, Yuldashev N, Karimova S, Nazira A, Ikramova S, Suleymanova G, et al. Impact of Chronic Sodium Cyclamate Administration at a Daily Acceptable Dose on Carbohydrate Metabolism and Insulin Resistance. International Journal of Drug Delivery Technology. 2026;16(7s). doi:10.25258/ijddt.16.7s.10

BibTeX
@article{Khabibullaev2026,
  author = {Khabibullaev, Sanjarbek and Yuldashev, Nasirdjan and Karimova, Shaira and Nazira, Alimkhodjayeva and Ikramova, Surayyo and Suleymanova, Gulchekhra and Rashidova, Durdona},
  title = {Impact of Chronic Sodium Cyclamate Administration at a Daily Acceptable Dose on Carbohydrate Metabolism and Insulin Resistance},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {7s},
  doi = {10.25258/ijddt.16.7s.10}
}
Kostenlos starten →